Morning Overview on MSN
DNA-based system targets cancer cells by sensing 2 biomarkers
Researchers at the University of Geneva have built a molecular system that can tell the difference between a cancer cell and ...
Cells aren’t as passive as scientists once thought—they actively create internal currents to move proteins quickly and ...
A new CAR T-cell therapy attacks supportive cells in the tumor microenvironment that bear the surface protein, uPAR.
The current path to CAR-T cell therapy is, by any measure, a logistical ordeal. A patient’s immune cells must be drawn out of the body, shipped to a specialized facility, genetically reprogrammed, ...
For his work towards developing a novel cancer immunotherapy that turns tumors into their own vaccines, Fábio Rosa has ...
Scientists in Canada have uncovered a surprising weakness in glioblastoma, one of the deadliest brain cancers. They found ...
This post was updated March 31 at 11:21 p.m. UCLA researchers developed a human stem cell-derived cell therapy for an ...
Yerem Yeghiazarians, MD, discusses the importance of understanding why certain cells (like cancer cells) can survive in ...
Tumours have developed many strategies and tricks to gain advantages in the body. Led by cell biology professor Sabine Werner, researchers at ETH Zurich have now discovered another surprising trick ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results